Metabolism remodeling in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of death of patients with malignant cancers by 2030. Current options of PDAC treatment are limited and the five-year survival rate is less than 8%, leading to an urgent need to explore innovatively therapeutic st...

Full description

Bibliographic Details
Main Authors: Jin-Tao Li, Yi-Ping Wang, Miao Yin, Qun-Ying Lei
Format: Article
Language:English
Published: Shared Science Publishers OG 2019-11-01
Series:Cell Stress
Subjects:
Online Access:http://www.cell-stress.com/researcharticles/2019b-li-cell-stress/